Literature DB >> 16769444

Heroin dependence and HIV infection in Malaysia.

Marek C Chawarski1, Mahmud Mazlan, Richard S Schottenfeld.   

Abstract

BACKGROUND: Malaysia is experiencing severe problems with heroin dependence and HIV infection. This, study evaluated drug use and other HIV risk behaviors and their association with HIV and other infectious diseases in heroin-dependent subjects enrolled in a clinical trial of drug abuse treatment in Muar, Malaysia.
METHODS: Baseline assessment of treatment-seeking subjects (n=177) included the Addiction Severity Index; AIDS Risk Inventory; serological tests for HIV, hepatitis B, and hepatitis C; and chest X-ray.
RESULTS: All of the subjects were male; 67.8% were Malays, 28.8% Chinese, and 2.3%. Indian. Subjects had a mean (SD) age of 37.2 (9.1) years and 14.4 (8.5) years of using heroin; 76.3% reported lifetime injection drug use (IDU), and 41.5% reported current IDU; 30 of 156 (19.2%) tested HIV positive, 143 of 159 (89.9%) tested hepatitis C positive, and 25 of 159 (15.7%) had radiological evidence of pulmonary tuberbulosis. Malay subjects had a significantly higher prevalence of current IDU, needle sharing (p<0.01), and HIV infection (p<0.05) compared with Chinese subjects. Lifetime IDU, needle sharing, lack of consistent condom use, and Malay ethnicity were significantly associated with HIV infection.
CONCLUSIONS: The high prevalence of HIV infection among heroin-dependent individuals, in Malaysia supports the important of interventions to reduce the major risk factors for HIV, including IDU, needle sharing, and unprotected sex.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16769444     DOI: 10.1016/s0376-8716(06)80007-4

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  9 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

Review 2.  Pharmacogenomics of CYP3A: considerations for HIV treatment.

Authors:  Sukhwinder S Lakhman; Qing Ma; Gene D Morse
Journal:  Pharmacogenomics       Date:  2009-08       Impact factor: 2.533

Review 3.  The globalization of addiction research: capacity-building mechanisms and selected examples.

Authors:  Richard A Rawson; George Woody; Thomas F Kresina; Steven Gust
Journal:  Harv Rev Psychiatry       Date:  2015 Mar-Apr       Impact factor: 3.732

4.  Therapeutic drug monitoring of protease inhibitors and efavirenz in HIV-infected individuals with active substance-related disorders.

Authors:  Qing Ma; Barry S Zingman; Amneris E Luque; Margaret A Fischl; Barbara M Gripshover; Charles S Venuto; Robin DiFrancesco; Alan Forrest; Gene D Morse
Journal:  Ther Drug Monit       Date:  2011-06       Impact factor: 3.681

5.  Costs of addressing heroin addiction in Malaysia and 32 comparable countries worldwide.

Authors:  Jennifer Prah Ruger; Marek Chawarski; Mahmud Mazlan; Craig Luekens; Nora Ng; Richard Schottenfeld
Journal:  Health Serv Res       Date:  2011-10-18       Impact factor: 3.402

6.  Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial.

Authors:  Richard S Schottenfeld; Marek C Chawarski; Mahmud Mazlan
Journal:  Lancet       Date:  2008-06-28       Impact factor: 79.321

7.  Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders.

Authors:  Cindy Bednasz; Amneris E Luque; Barry S Zingman; Margaret A Fischl; Barbara M Gripshover; Charles S Venuto; Jie Gu; Zekun Feng; Robin DiFrancesco; Gene D Morse; Qing Ma
Journal:  Curr Vasc Pharmacol       Date:  2016       Impact factor: 2.719

8.  Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors.

Authors:  Lynn E Sullivan; Brent A Moore; Marek C Chawarski; Michael V Pantalon; Declan Barry; Patrick G O'Connor; Richard S Schottenfeld; David A Fiellin
Journal:  J Subst Abuse Treat       Date:  2007-10-15

9.  Bridging the data gaps in the epidemiology of hepatitis C virus infection in Malaysia using multi-parameter evidence synthesis.

Authors:  Scott A McDonald; Rosmawati Mohamed; Maznah Dahlui; Herlianna Naning; Adeeba Kamarulzaman
Journal:  BMC Infect Dis       Date:  2014-11-07       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.